Cite
Clinical significance of decreased programmed cell death 4 expression in patients with giant cell tumors of the bone.
MLA
Gao, Fei, et al. “Clinical Significance of Decreased Programmed Cell Death 4 Expression in Patients with Giant Cell Tumors of the Bone.” Oncology Letters, vol. 16, no. 3, Sept. 2018, pp. 3805–11. EBSCOhost, https://doi.org/10.3892/ol.2018.9087.
APA
Gao, F., Zhang, W., Ding, L., Zhao, M., Ma, Z., & Huang, S. (2018). Clinical significance of decreased programmed cell death 4 expression in patients with giant cell tumors of the bone. Oncology Letters, 16(3), 3805–3811. https://doi.org/10.3892/ol.2018.9087
Chicago
Gao, Fei, Wei Zhang, Lingling Ding, Miaoqing Zhao, Zhe Ma, and Shanying Huang. 2018. “Clinical Significance of Decreased Programmed Cell Death 4 Expression in Patients with Giant Cell Tumors of the Bone.” Oncology Letters 16 (3): 3805–11. doi:10.3892/ol.2018.9087.